Brown Technology Innovations
Date July 1, 2020
All News

Leaders in Regenerative Medicine: Kareen Coulombe and Diane Hoffman-Kim

Regenerative medicine, an emerging field, allows a broad range of testing for toxicity and other health threats without using animal testing. Two Brown researchers, Dr. Kareen Coulombe and Dr. Diane Hoffman-Kim have been part of the Bioengineering Research Partnerships project, funded in 2016 by the NHLBI (National Heart Lung and Blood Institute).

Kareen Coulombe and Diane Hoffman-Kim
Dr. Kareen Coulombe (left), Assistant Professor of Engineering, Director of Biomedical Engineering, Assistant Professor of Molecular Pharmacology, Physiology and Biotechnology; Dr. Diane Hoffman-Kim (right), Associate Professor of Medical Science, Associate Professor of Engineering

In its final stages of the 5 year award, the Advisory Board selected 2 of the 5 teams to be the focal point of the remaining funds; Dr. Coulombe and Dr. Hoffman-Kim were selected. Coulombe studies heart tissue and Hoffman-Kim studies nerve fibers. Brown Technology Innovations has received interest from bioengineering companies for technologies that could emerge from their work.